Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ABCA2,ATP-binding cassette sub-family A member 2,2060,56,3.43 [2.24-5.26],1.3968322605141224e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACAN,Aggrecan core protein,2430,81,3.19 [1.60-6.34],0.0009560812906392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACP5,Tartrate-resistant acid phosphatase type 5,2473,84,2.74 [1.67-4.50],7.033010427161588e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACP6,Lysophosphatidic acid phosphatase type 6,2472,84,2.11 [1.45-3.08],9.759643182538618e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACRV1,Acrosomal protein SP-10,2062,59,1.45 [1.19-1.77],0.0002088464083366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACTA2,"Actin, aortic smooth muscle",2415,83,2.65 [2.20-3.19],1.4290302712850148e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACTN4,Alpha-actinin-4,2404,82,1.65 [1.18-2.31],0.003440484616504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACVRL1,Serine/threonine-protein kinase receptor R3,2433,83,13.91 [9.57-20.23],3.3964797536289324e-43
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,2060,56,2.00 [1.40-2.84],0.0001283817843526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADA2,Adenosine deaminase 2,2443,83,3.18 [2.32-4.36],8.01518583935901e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,2062,59,4.38 [3.05-6.29],1.1883948727933354e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,2415,83,2.45 [1.36-4.44],0.0029733554814338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,2437,83,10.39 [6.55-16.49],2.803668106707724e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,2490,84,15.49 [8.25-29.10],1.5795824628724518e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,2473,84,3.93 [2.57-6.03],3.2537693897960177e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,2124,60,8.62 [5.95-12.48],4.290695417893518e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,2062,59,3.83 [2.06-7.11],2.138595700235204e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,2439,83,3.56 [2.64-4.80],8.100219841803001e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,2415,83,1.78 [1.22-2.60],0.0027032159897086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,2062,59,2.27 [1.29-3.98],0.004284435063974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTSL2,ADAMTS-like protein 2,2130,58,2.67 [1.56-4.57],0.0003361584419277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTSL5,ADAMTS-like protein 5,2122,60,2.16 [1.38-3.39],0.0007775231226129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADD1,Alpha-adducin,2085,56,0.58 [0.40-0.84],0.0036382686758877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRB3,Adhesion G protein-coupled receptor B3,2433,83,11.06 [6.78-18.03],5.439811414781244e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRE1,Adhesion G protein-coupled receptor E1,2124,60,2.51 [1.74-3.60],6.822137713548071e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRE2,Adhesion G protein-coupled receptor E2,2472,83,8.76 [5.07-15.13],7.547651188217294e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRE5,Adhesion G protein-coupled receptor E5,2480,84,5.68 [3.72-8.68],9.989866258175611e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRG1,Adhesion G-protein coupled receptor G1,2439,83,1.35 [1.16-1.58],0.0001270205646406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRG2,Adhesion G-protein coupled receptor G2,2457,82,0.34 [0.18-0.64],0.0007588845855461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADM,Pro-adrenomedullin,2475,84,38.48 [20.06-73.81],4.691564163978379e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AFM,Afamin,2126,59,0.15 [0.06-0.36],2.248798308049016e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AFP,Alpha-fetoprotein,2430,83,0.47 [0.34-0.64],2.499811449574679e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGER,Advanced glycosylation end product-specific receptor,2459,83,4.35 [2.97-6.38],5.4478661917350304e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGR2,Anterior gradient protein 2 homolog,2375,79,1.62 [1.36-1.93],6.892068033803403e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGRN,Agrin,2472,83,5.53 [4.10-7.44],2.042838434355585e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGRP,Agouti-related protein,2490,84,3.09 [2.10-4.56],1.2431711015852886e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AHNAK,Neuroblast differentiation-associated protein AHNAK,2059,54,3.38 [1.96-5.81],1.0798346162628548e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AHNAK2,Protein AHNAK2,2059,54,3.28 [2.15-4.99],3.303643735287241e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AK1,Adenylate kinase isoenzyme 1,2457,82,0.61 [0.45-0.85],0.0027879550134766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AKR1C4,Aldo-keto reductase family 1 member C4,2415,83,1.85 [1.40-2.45],1.778813567538963e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ALCAM,CD166 antigen,2490,84,15.10 [7.02-32.49],3.761615455060609e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMBP,Protein AMBP,2473,84,45.91 [24.65-85.52],1.7593943780681436e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMN,Protein amnionless,2404,82,1.95 [1.31-2.89],0.0010242912835949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANG,Angiogenin,2455,83,3.86 [2.49-5.98],1.7315539437305247e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPT2,Angiopoietin-2,2475,84,4.02 [2.71-5.96],4.559476074732578e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPTL1,Angiopoietin-related protein 1,2415,80,3.94 [2.12-7.33],1.506008026101968e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPTL3,Angiopoietin-related protein 3,2460,83,1.97 [1.19-3.25],0.008009643994096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPTL4,Angiopoietin-related protein 4,2471,83,5.15 [3.46-7.65],5.29466831796589e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPTL7,Angiopoietin-related protein 7,2475,84,2.98 [1.97-4.52],2.542811249489719e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANXA10,Annexin A10,2393,81,1.37 [1.13-1.66],0.0016092816699977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANXA5,Annexin A5,2385,80,3.10 [2.24-4.28],7.37047488427515e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AOC3,Membrane primary amine oxidase,2464,83,10.09 [5.73-17.77],1.1204391272511997e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOA1,Apolipoprotein A-I,2126,59,0.21 [0.08-0.53],0.0009254698145825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOA2,Apolipoprotein A-II,2130,61,3.08 [2.01-4.72],2.548802281108101e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOA4,Apolipoprotein A-IV,2126,59,5.49 [3.54-8.52],2.9749805165736315e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOC1,Apolipoprotein C-I,2121,59,0.35 [0.19-0.62],0.0003771656460747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOH,Beta-2-glycoprotein 1,2467,84,1.80 [1.19-2.73],0.005051858126149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOM,Apolipoprotein M,2464,83,0.38 [0.20-0.71],0.002540346133782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AREG,Amphiregulin,2439,83,4.24 [3.17-5.67],2.13881865528398e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARG1,Arginase-1,2423,83,0.53 [0.37-0.77],0.000796667834568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ART3,Ecto-ADP-ribosyltransferase 3,2464,83,7.44 [5.26-10.53],9.090094893082304e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASGR1,Asialoglycoprotein receptor 1,2437,83,7.62 [5.23-11.12],4.851542648596578e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASGR2,Asialoglycoprotein receptor 2,2130,61,18.77 [9.84-35.81],5.630462982690782e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP6AP2,Renin receptor,2383,81,1.94 [1.35-2.77],0.0002988802638525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AXL,Tyrosine-protein kinase receptor UFO,2464,83,7.65 [4.35-13.43],1.445137961777782e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",B2M,Beta-2-microglobulin,2126,59,9.54 [5.94-15.32],1.09404214327789e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",2059,54,3.78 [1.88-7.62],0.0001968820207582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",B4GALT1,"Beta-1,4-galactosyltransferase 1",2472,83,16.43 [10.84-24.91],1.157085981549024e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",B4GAT1,"Beta-1,4-glucuronyltransferase 1",2467,84,5.03 [2.26-11.20],7.508796016067165e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BAG3,BAG family molecular chaperone regulator 3,2433,83,2.46 [1.55-3.91],0.0001323999200851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BAMBI,BMP and activin membrane-bound inhibitor homolog,2383,81,3.77 [2.82-5.04],4.129002409327902e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCAM,Basal cell adhesion molecule,2467,84,4.04 [1.92-8.49],0.0002275349426878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCL2,Apoptosis regulator Bcl-2,2124,60,1.85 [1.43-2.38],2.6078320887213724e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",2461,84,3.71 [2.15-6.42],2.7321497667595742e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BMP10,Bone morphogenetic protein 10,2085,56,3.10 [1.80-5.35],4.611956122596989e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BMP4,Bone morphogenetic protein 4,2433,83,1.59 [1.14-2.24],0.0070217873344563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BMPER,BMP-binding endothelial regulator protein,2085,56,7.74 [4.69-12.80],1.412584447282643e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,2062,59,2.00 [1.29-3.08],0.0018103746556157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BOC,Brother of CDO,2415,83,10.29 [5.22-20.28],1.608469866497663e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BSG,Basigin,2484,84,27.17 [15.93-46.34],7.680906872993596e-34
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BST2,Bone marrow stromal antigen 2,2476,84,1.75 [1.32-2.32],0.0001183585472052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BTN2A1,Butyrophilin subfamily 2 member A1,2472,83,14.79 [8.20-26.69],3.7465472983479767e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BTN3A2,Butyrophilin subfamily 3 member A2,2461,84,5.62 [3.99-7.91],6.032470034768913e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1QA,Complement C1q subcomponent subunit A,2476,84,11.55 [5.51-24.23],9.582238284348463e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,2464,83,1.92 [1.46-2.52],3.092001690700488e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C2,Complement C2,2464,83,6.73 [2.53-17.90],0.0001326856002382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C2CD2L,Phospholipid transfer protein C2CD2L,2389,81,2.10 [1.50-2.93],1.404508532724042e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C7,Complement component C7,2077,59,3.33 [1.72-6.46],0.0003740482989461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA1,Carbonic anhydrase 1,2419,82,0.63 [0.45-0.88],0.0068254468243733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA12,Carbonic anhydrase 12,2439,83,10.05 [6.98-14.48],2.9293117283539777e-35
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA14,Carbonic anhydrase 14,2475,84,5.35 [3.61-7.93],6.46398860488088e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA2,Carbonic anhydrase 2,2457,84,0.61 [0.46-0.81],0.0008058163886017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA3,Carbonic anhydrase 3,2488,84,1.66 [1.25-2.21],0.0004460121687494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA4,Carbonic anhydrase 4,2490,84,8.29 [4.28-16.08],3.72009760762915e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA5A,"Carbonic anhydrase 5A, mitochondrial",2415,83,1.43 [1.21-1.70],3.001332672862983e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA6,Carbonic anhydrase 6,2461,83,0.66 [0.49-0.89],0.0058570370451119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA9,Carbonic anhydrase 9,2475,84,2.52 [1.93-3.29],1.0762755642424014e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALB1,Calbindin,2439,83,3.51 [2.59-4.76],6.823855210850175e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALB2,Calretinin,2393,81,4.68 [3.09-7.07],2.577735054661092e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALCA,Calcitonin,2433,83,2.08 [1.69-2.56],3.362105374655452e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALCB,Calcitonin gene-related peptide 2,2116,60,3.08 [2.37-3.99],3.683125815713665e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CANT1,Soluble calcium-activated nucleotidase 1,2448,82,12.50 [5.29-29.51],8.277613977863488e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CAPG,Macrophage-capping protein,2435,83,2.06 [1.61-2.63],6.8636299283497525e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CAT,Catalase,2098,60,0.47 [0.30-0.75],0.0014542148354788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CBLIF,Cobalamin binding intrinsic factor,2457,82,1.75 [1.40-2.18],7.487244310182146e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCDC80,Coiled-coil domain-containing protein 80,2457,82,6.69 [4.65-9.61],1.1110804389372451e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,2059,54,2.10 [1.58-2.79],2.587342235203552e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL11,Eotaxin,2490,84,3.63 [2.28-5.79],6.091902965580605e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL14,C-C motif chemokine 14,2455,83,3.48 [2.60-4.66],5.088866124102695e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL15,C-C motif chemokine 15,2490,84,4.17 [3.05-5.71],4.256929094978071e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL16,C-C motif chemokine 16,2490,84,2.62 [1.84-3.74],1.0100837365925845e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL2,C-C motif chemokine 2,2433,83,1.65 [1.15-2.36],0.0061997302574095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL20,C-C motif chemokine 20,2490,84,1.54 [1.33-1.79],1.4134385056361369e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL21,C-C motif chemokine 21,2472,83,2.18 [1.70-2.80],1.269065785392206e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL23,C-C motif chemokine 23,2472,83,2.98 [1.96-4.53],3.376961302340668e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL25,C-C motif chemokine 25,2490,84,3.11 [2.17-4.46],6.541456822680491e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL27,C-C motif chemokine 27,2457,82,1.65 [1.19-2.28],0.0024661727163776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL3,C-C motif chemokine 3,2461,84,1.45 [1.24-1.70],4.521440972799555e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL7,C-C motif chemokine 7,2461,84,1.61 [1.21-2.15],0.0011381937369862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL8,C-C motif chemokine 8,2473,84,1.77 [1.28-2.45],0.0005770385729413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCN3,CCN family member 3,2484,84,6.94 [5.09-9.47],2.2331685313850113e-34
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCN4,CCN family member 4,2475,84,5.93 [4.16-8.45],6.890446457279679e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCN5,CCN family member 5,2467,84,7.60 [5.15-11.21],1.4920204853899241e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCS,Copper chaperone for superoxide dismutase,2437,83,0.36 [0.23-0.56],4.719120706725574e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD109,CD109 antigen,2467,84,3.27 [1.93-5.53],1.014663998529278e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD14,Monocyte differentiation antigen CD14,2417,82,5.63 [3.81-8.32],3.7914278377598455e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD160,CD160 antigen,2490,84,4.88 [3.74-6.37],2.5500151394944363e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD163,Scavenger receptor cysteine-rich type 1 protein M130,2464,83,1.95 [1.31-2.92],0.0011163137157053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD164,Sialomucin core protein 24,2467,84,2.82 [1.99-4.00],6.228677652062378e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD200,OX-2 membrane glycoprotein,2461,84,4.24 [2.90-6.20],9.93055407713854e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD207,C-type lectin domain family 4 member K,2393,81,5.45 [3.57-8.33],4.378271718484356e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD209,CD209 antigen,2471,83,2.50 [1.49-4.20],0.0005381540428362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD244,Natural killer cell receptor 2B4,2490,84,3.72 [2.08-6.66],9.965080892027184e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD248,Endosialin,2130,58,3.50 [2.02-6.04],7.384349786731448e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD27,CD27 antigen,2456,83,7.58 [5.75-9.99],1.0564651151849895e-46
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD274,Programmed cell death 1 ligand 1,2437,83,3.39 [2.54-4.53],1.5597729263530872e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD276,CD276 antigen,2462,83,9.77 [6.32-15.11],1.1659587434789981e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD28,T-cell-specific surface glycoprotein CD28,2383,81,3.20 [2.15-4.74],7.93512877353016e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD300A,CMRF35-like molecule 8,2085,56,17.90 [9.62-33.30],8.163900215722731e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD300C,CMRF35-like molecule 6,2476,84,13.08 [8.60-19.90],3.092053538403261e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD300E,CMRF35-like molecule 2,2469,84,6.54 [4.75-9.02],2.112779405947248e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD300LF,CMRF35-like molecule 1,2475,84,3.29 [2.42-4.49],5.148186247442095e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD300LG,CMRF35-like molecule 9,2467,84,7.37 [5.13-10.61],4.2559323288105576e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD302,CD302 antigen,2439,83,8.93 [6.51-12.27],1.0100077237289732e-41
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD34,Hematopoietic progenitor cell antigen CD34,2471,84,3.96 [1.87-8.40],0.0003212810575138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,2439,83,8.34 [5.60-12.42],1.560555360209007e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD4,T-cell surface glycoprotein CD4,2460,84,5.39 [3.86-7.55],7.179467706523162e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD40,Tumor necrosis factor receptor superfamily member 5,2466,83,1.94 [1.45-2.60],7.981380603911647e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD46,Membrane cofactor protein,2446,83,10.53 [6.33-17.51],1.1655658743311356e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD48,CD48 antigen,2471,83,12.83 [7.57-21.75],2.6601196092611425e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD5,T-cell surface glycoprotein CD5,2473,84,3.84 [2.95-4.98],7.126918105503492e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD55,Complement decay-accelerating factor,2374,77,5.90 [4.13-8.45],2.7318546474160375e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD58,Lymphocyte function-associated antigen 3,2455,83,7.09 [2.33-21.62],0.0005680557328501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD59,CD59 glycoprotein,2364,80,12.60 [8.49-18.71],2.866278892163409e-36
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD5L,CD5 antigen-like,2114,59,1.98 [1.21-3.24],0.0067290966668646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD7,T-cell antigen CD7,2056,59,4.35 [3.18-5.95],3.2787707650098314e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD70,CD70 antigen,2461,84,2.20 [1.51-3.20],3.543987362305687e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD72,B-cell differentiation antigen CD72,2085,56,4.15 [2.89-5.96],1.2010632241772252e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD74,HLA class II histocompatibility antigen gamma chain,2476,84,12.22 [8.27-18.08],4.518652545555267e-36
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD79B,B-cell antigen receptor complex-associated protein beta chain,2490,84,6.10 [4.76-7.83],7.491140515434352e-46
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD80,T-lymphocyte activation antigen CD80,2122,60,3.92 [2.27-6.78],9.913539939374313e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD83,CD83 antigen,2461,84,6.50 [4.43-9.54],1.1579539176930317e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD8A,T-cell surface glycoprotein CD8 alpha chain,2476,84,1.86 [1.36-2.55],0.0001072776440608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD93,Complement component C1q receptor,2385,79,9.23 [6.20-13.75],8.147169780544219e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD99,CD99 antigen,2467,84,27.85 [14.64-52.98],3.664543196303516e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD99L2,CD99 antigen-like protein 2,2467,84,16.60 [9.03-30.53],1.6166384365588294e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH1,Cadherin-1,2376,78,3.02 [2.39-3.82],2.6320514511819687e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH15,Cadherin-15,2472,84,1.40 [1.15-1.70],0.0007305723331461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH17,Cadherin-17,2457,82,1.74 [1.37-2.20],4.128518402229105e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH2,Cadherin-2,2457,82,1.92 [1.27-2.88],0.0018097424259281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH3,Cadherin-3,2476,84,7.24 [5.20-10.08],8.608965354752532e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH5,Cadherin-5,2490,84,3.34 [1.85-6.01],6.0072502932562496e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH6,Cadherin-6,2457,82,3.09 [1.98-4.81],6.436457913321289e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDNF,Cerebral dopamine neurotrophic factor,2439,83,2.05 [1.73-2.43],1.4016553659949906e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDSN,Corneodesmosin,2480,84,4.98 [3.53-7.05],9.65651406213806e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,2124,60,3.36 [2.31-4.89],2.2396291346906542e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,2461,84,1.42 [1.16-1.73],0.0007673468357756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,2357,79,1.62 [1.21-2.16],0.0012891773143944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,2415,83,2.33 [1.69-3.21],2.0808126096013602e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,2085,56,7.16 [3.93-13.04],1.1988956487866634e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEND1,Cell cycle exit and neuronal differentiation protein 1,2061,56,1.47 [1.15-1.86],0.0017187720573297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CENPF,Centromere protein F,2091,58,0.43 [0.25-0.74],0.0020237647266093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFC1,Cryptic protein,2383,81,1.98 [1.52-2.57],3.058642805795915e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFD,Complement factor D,2126,59,13.44 [7.12-25.35],1.0437266115780197e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFP,Properdin,2126,59,0.24 [0.09-0.63],0.0036881279435997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CGA,Glycoprotein hormones alpha chain,2467,84,2.21 [1.81-2.71],2.0631176954846926e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CGREF1,Cell growth regulator with EF hand domain protein 1,2457,82,5.99 [4.27-8.42],4.979722904698538e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",2116,60,7.26 [5.15-10.23],9.036352338050044e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHCHD6,MICOS complex subunit MIC25,2117,60,2.48 [1.72-3.60],1.4594352991827389e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHGA,Chromogranin-A,2130,58,1.76 [1.50-2.07],3.0945590296058256e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHGB,Secretogranin-1,2466,84,6.99 [4.94-9.88],3.937801799748194e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHI3L1,Chitinase-3-like protein 1,2404,81,1.73 [1.43-2.09],2.0497508117496785e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHRDL1,Chordin-like protein 1,2471,83,15.40 [9.92-23.90],3.648320726268535e-34
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CILP,Cartilage intermediate layer protein 1,2130,58,5.28 [3.39-8.24],2.1310897895878322e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CKAP4,Cytoskeleton-associated protein 4,2479,84,5.67 [4.48-7.18],5.105515667594722e-47
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CKB,Creatine kinase B-type,2130,58,3.41 [2.46-4.72],1.2766320827219466e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLC,Galectin-10,2453,82,1.75 [1.37-2.22],5.2919323271035135e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC10A,C-type lectin domain family 10 member A,2437,83,4.23 [2.55-7.02],2.473311548603798e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC12A,C-type lectin domain family 12 member A,2062,59,3.91 [1.51-10.12],0.0050533915840274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC14A,C-type lectin domain family 14 member A,2467,84,12.32 [8.53-17.80],7.292945028646614e-41
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC1A,C-type lectin domain family 1 member A,2415,83,7.25 [5.02-10.46],3.8815695123438196e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC4D,C-type lectin domain family 4 member D,2461,84,2.36 [1.86-2.98],8.708918910200746e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC4G,C-type lectin domain family 4 member G,2461,84,2.65 [1.49-4.73],0.0009460283258802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC5A,C-type lectin domain family 5 member A,2452,82,6.11 [4.02-9.28],2.245525829795111e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC6A,C-type lectin domain family 6 member A,2383,81,2.60 [1.95-3.48],9.686622062011014e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC7A,C-type lectin domain family 7 member A,2490,84,4.74 [3.46-6.48],2.115520179646304e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLGN,Calmegin,2076,58,3.24 [2.14-4.90],2.9446493517877105e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLIC5,Chloride intracellular channel protein 5,2076,58,2.47 [1.61-3.79],3.5326322977157694e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLMP,CXADR-like membrane protein,2475,84,32.33 [19.76-52.92],1.6646968729422353e-43
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLSTN2,Calsyntenin-2,2490,84,2.08 [1.47-2.94],3.496203359729398e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTN1,Contactin-1,2490,84,4.66 [2.35-9.27],1.1188757789331624e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTN2,Contactin-2,2475,84,2.42 [1.61-3.65],2.262637830102838e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTNAP2,Contactin-associated protein-like 2,2461,84,1.83 [1.26-2.66],0.001481596529894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COCH,Cochlin,2122,60,2.29 [1.50-3.50],0.0001264450686452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL15A1,Collagen alpha-1(XV) chain,2130,58,7.88 [4.51-13.75],3.9078065155410793e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL18A1,Collagen alpha-1(XVIII) chain,2470,84,40.86 [22.20-75.19],9.097826148631064e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL1A1,Collagen alpha-1(I) chain,2490,84,2.78 [1.48-5.24],0.0015189447571358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL24A1,Collagen alpha-1(XXIV) chain,2124,60,2.46 [1.57-3.85],8.451063021999384e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL4A1,Collagen alpha-1(IV) chain,2457,82,2.62 [1.96-3.50],8.009492443121055e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL5A1,Collagen alpha-1(V) chain,2085,56,1.79 [1.29-2.51],0.000594459001076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL6A3,Collagen alpha-3(VI) chain,2490,84,8.91 [6.49-12.24],1.4805774493130663e-41
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COLEC12,Collectin-12,2462,83,20.14 [13.20-30.74],4.784330713900447e-44
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CORO6,Coronin-6,2061,56,1.87 [1.36-2.56],9.948277037005524e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPA2,Carboxypeptidase A2,2470,84,1.70 [1.35-2.15],8.313739904136156e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPA4,Carboxypeptidase A4,2040,54,3.85 [2.15-6.88],5.366603870687656e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPTP,Ceramide-1-phosphate transfer protein,2060,56,2.08 [1.19-3.63],0.0099691775625537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPVL,Probable serine carboxypeptidase CPVL,2471,84,2.82 [1.74-4.58],2.514965559500236e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPXM2,Inactive carboxypeptidase-like protein X2,2122,60,14.52 [7.43-28.35],4.679612222542034e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CR2,Complement receptor type 2,2464,83,2.07 [1.45-2.94],5.661325623715142e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRELD1,Protein disulfide isomerase CRELD1,2085,56,5.47 [2.92-10.26],1.122908840066287e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRELD2,Protein disulfide isomerase CRELD2,2471,83,2.61 [1.99-3.44],6.685520739930941e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRHBP,Corticotropin-releasing factor-binding protein,2462,83,10.02 [5.09-19.71],2.4682059708245704e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRIM1,Cysteine-rich motor neuron 1 protein,2472,83,39.03 [19.20-79.34],4.351014809991508e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRIP2,Cysteine-rich protein 2,2437,83,3.81 [2.75-5.27],9.827261173629857e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRLF1,Cytokine receptor-like factor 1,2472,83,4.38 [2.05-9.38],0.0001441814218449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRNN,Cornulin,2372,82,1.60 [1.22-2.08],0.0005302201617611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRTAM,Cytotoxic and regulatory T-cell molecule,2437,83,2.73 [1.90-3.92],5.800263164661305e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSF1,Macrophage colony-stimulating factor 1,2472,83,26.06 [15.16-44.81],4.202295014459521e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSF1R,Macrophage colony-stimulating factor 1 receptor,2130,61,2.33 [1.38-3.91],0.0014340575007869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,2437,83,1.51 [1.15-1.98],0.0033813666924215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSPG4,Chondroitin sulfate proteoglycan 4,2130,58,7.84 [4.15-14.83],2.361579520862768e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSRP3,Cysteine and glycine-rich protein 3,2060,56,1.43 [1.16-1.75],0.0006093764869432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CST1,Cystatin-SN,1855,47,1.64 [1.32-2.04],6.7911212769631135e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CST3,Cystatin-C,2455,82,10.81 [7.25-16.11],1.411196435607013e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CST5,Cystatin-D,2414,82,1.72 [1.23-2.39],0.0014207636636997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CST6,Cystatin-M,2390,82,4.57 [3.30-6.33],7.166215252488274e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSTB,Cystatin-B,2434,81,2.84 [1.88-4.29],6.760209216119418e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTHRC1,Collagen triple helix repeat-containing protein 1,2130,58,7.00 [4.30-11.39],4.615358529771717e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTRC,Chymotrypsin-C,2466,83,0.72 [0.56-0.91],0.0058941390316989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSB,Cathepsin B,2460,84,2.86 [2.10-3.88],1.7231482600495088e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSD,Cathepsin D,2310,76,1.73 [1.17-2.56],0.0059793914246327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSE,Cathepsin E,2085,56,1.81 [1.17-2.81],0.0079211603320379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSH,Pro-cathepsin H,2411,83,1.64 [1.27-2.13],0.0001748089920777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSL,Cathepsin L1,2457,82,5.61 [3.24-9.71],7.303584422658438e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSO,Cathepsin O,2490,84,4.58 [2.93-7.18],3.086656148168341e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSS,Cathepsin S,1965,73,5.76 [2.60-12.72],1.536520196920392e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSV,Cathepsin L2,2466,84,0.43 [0.27-0.70],0.0006735310747274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSZ,Cathepsin Z,2458,83,7.15 [4.44-11.52],5.933679703443913e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CX3CL1,Fractalkine,2437,83,6.25 [4.44-8.79],7.608089954101911e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXADR,Coxsackievirus and adenovirus receptor,2461,84,3.64 [2.65-4.99],1.3117904008339468e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL13,C-X-C motif chemokine 13,2476,84,1.37 [1.09-1.73],0.0074616583137642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL14,C-X-C motif chemokine 14,2404,82,1.44 [1.15-1.79],0.0013485949414574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL16,C-X-C motif chemokine 16,2489,84,18.11 [9.63-34.03],2.3284936053579724e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL9,C-X-C motif chemokine 9,2472,83,2.28 [1.85-2.81],7.922670306100654e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CYB5R2,NADH-cytochrome b5 reductase 2,2098,59,1.70 [1.16-2.48],0.0060124890062276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CYTL1,Cytokine-like protein 1,2130,58,8.73 [4.76-16.01],2.578530988190365e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DAND5,DAN domain family member 5,2062,59,0.66 [0.49-0.89],0.0074519079288383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",2456,83,6.90 [4.16-11.44],7.820966707933577e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCC,Netrin receptor DCC,2076,58,0.16 [0.05-0.48],0.0012359967306339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCN,Decorin,2415,83,10.19 [5.45-19.05],3.411717719967698e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCTPP1,dCTP pyrophosphatase 1,2457,82,2.61 [1.50-4.54],0.0007105410413739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",2439,83,2.20 [1.52-3.19],2.9506703954971868e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDI2,Protein DDI1 homolog 2,2085,56,0.63 [0.44-0.88],0.0073996399625653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDR1,Epithelial discoidin domain-containing receptor 1,2476,84,7.67 [4.22-13.93],2.248846073570948e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DEFA1_DEFA1B,Neutrophil defensin 1,2412,80,2.61 [2.08-3.28],1.7020924034063862e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DHPS,Deoxyhypusine synthase,2117,60,1.76 [1.15-2.70],0.0090995120921185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DIPK2B,Divergent protein kinase domain 2B,2085,56,2.49 [1.29-4.84],0.0068362959848286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DKK3,Dickkopf-related protein 3,2490,84,10.93 [6.18-19.33],2.01942440589247e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DKK4,Dickkopf-related protein 4,2433,83,3.26 [2.47-4.31],1.090610083842774e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DLK1,Protein delta homolog 1,2490,84,2.59 [1.91-3.51],9.264911181888435e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DLL1,Delta-like protein 1,2456,83,21.84 [14.27-33.43],8.702998605466617e-46
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DMD,Dystrophin,2059,54,2.49 [1.78-3.48],8.458646745866257e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DMP1,Dentin matrix acidic phosphoprotein 1,2059,54,0.44 [0.32-0.61],5.968995345199489e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNER,Delta and Notch-like epidermal growth factor-related receptor,2460,83,0.38 [0.19-0.78],0.0083005723605818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNM3,Dynamin-3,2118,60,2.13 [1.52-3.00],1.2573967611635644e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPP4,Dipeptidyl peptidase 4,2419,81,0.47 [0.26-0.83],0.0097501478589435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPP6,Dipeptidyl aminopeptidase-like protein 6,2439,83,2.19 [1.37-3.52],0.0011102137856676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPT,Dermatopontin,2490,84,41.34 [18.57-92.03],7.91018888950547e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPY30,Protein dpy-30 homolog,2469,84,1.97 [1.57-2.46],4.132534600388563e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DRAXIN,Draxin,2437,83,5.03 [3.50-7.23],3.0534005970654375e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DSC2,Desmocollin-2,2443,83,9.39 [6.62-13.33],4.5247419009918414e-36
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DSCAM,Down syndrome cell adhesion molecule,2118,60,2.41 [1.34-4.33],0.0032678844485554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DSG2,Desmoglein-2,2467,84,5.88 [3.64-9.52],5.194964143720397e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DSG3,Desmoglein-3,2467,84,5.76 [3.66-9.05],3.4067472508204883e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DSG4,Desmoglein-4,2431,83,1.71 [1.23-2.37],0.0012545356227809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DTNB,Dystrobrevin beta,2113,59,3.42 [2.49-4.70],3.615707816517816e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DTX3,Probable E3 ubiquitin-protein ligase DTX3,2439,83,8.46 [5.21-13.75],6.566844729780977e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EBI3_IL27,Interleukin-27,2472,84,7.54 [4.35-13.06],5.84137815627152e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDA2R,Tumor necrosis factor receptor superfamily member 27,2475,84,7.88 [6.03-10.30],1.2738149727884238e-51
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDDM3B,Epididymal secretory protein E3-beta,2117,60,1.63 [1.14-2.32],0.0075017595411668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,2415,83,2.36 [1.59-3.50],2.0046538864916163e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDN1,Endothelin-1,2059,54,10.54 [5.65-19.65],1.3079565644966365e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFCAB14,EF-hand calcium-binding domain-containing protein 14,2124,60,9.64 [6.26-14.83],6.690978923435641e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,2463,83,11.21 [7.30-17.21],2.303252962827676e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFHD1,EF-hand domain-containing protein D1,2118,60,5.55 [3.90-7.91],2.1131749429613168e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFNA1,Ephrin-A1,2464,84,13.73 [9.66-19.51],2.952186606334709e-48
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFNA4,Ephrin-A4,2433,83,11.07 [8.08-15.16],1.3162055053519145e-50
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFNB2,Ephrin-B2,2076,58,1.71 [1.39-2.09],2.5838096080443805e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EGFL7,Epidermal growth factor-like protein 7,2383,81,2.49 [1.71-3.63],1.987051572868141e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EGFLAM,Pikachurin,2124,60,3.94 [2.65-5.86],1.3454939721422027e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF4B,Eukaryotic translation initiation factor 4B,2437,83,0.63 [0.45-0.88],0.0076944547791471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ELAVL4,ELAV-like protein 4,2061,56,1.34 [1.08-1.66],0.0082995136716887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ELN,Elastin,2122,60,9.21 [5.00-16.96],9.944533380710458e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENAH,Protein enabled homolog,2404,82,1.88 [1.43-2.47],6.986853184414155e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENDOU,Poly(U)-specific endoribonuclease,1961,55,3.80 [2.73-5.29],2.7282844995991524e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENG,Endoglin,2490,84,3.89 [1.39-10.86],0.0094625818315953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHA1,Ephrin type-A receptor 1,2465,83,11.71 [6.85-20.01],2.3388877427540013e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHA2,Ephrin type-A receptor 2,2361,82,11.64 [8.29-16.35],1.2017186022243982e-45
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHA4,Ephrin type-A receptor 4,2085,56,13.57 [6.49-28.36],4.098741934608749e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHB4,Ephrin type-B receptor 4,2490,84,25.09 [16.15-38.97],1.3473931456314544e-46
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHB6,Ephrin type-B receptor 6,2433,83,10.41 [7.12-15.22],1.273693813525189e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPO,Erythropoietin,2461,84,1.35 [1.09-1.66],0.0052960887310423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,2472,84,5.18 [3.51-7.66],1.517111737195418e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERMAP,Erythroid membrane-associated protein,2062,59,2.75 [1.67-4.52],7.06827459460902e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ESAM,Endothelial cell-selective adhesion molecule,2490,84,8.47 [5.60-12.81],4.0332687352629895e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F2R,Proteinase-activated receptor 1,2471,83,2.02 [1.44-2.84],5.001675790474362e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F3,Tissue factor,2459,84,11.32 [6.50-19.71],9.898407439585829e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP1,"Fatty acid-binding protein, liver",2462,83,2.16 [1.83-2.55],7.14170293606571e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP2,"Fatty acid-binding protein, intestinal",2457,82,1.82 [1.51-2.19],2.0377860047307554e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP3,"Fatty acid-binding protein, heart",2122,60,3.57 [2.77-4.59],9.375901205684368e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP4,"Fatty acid-binding protein, adipocyte",2490,84,3.40 [2.65-4.36],4.6714080769409005e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP6,Gastrotropin,2412,82,1.80 [1.42-2.30],1.8822463584990805e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP9,Fatty acid-binding protein 9,2461,84,2.03 [1.47-2.80],1.519291188897402e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM171B,Protein FAM171B,2117,60,3.21 [1.86-5.56],3.032545800311999e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM3B,Protein FAM3B,2439,83,9.04 [5.22-15.66],4.174560607034199e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM3C,Protein FAM3C,2457,82,17.26 [11.35-26.25],1.884665135862256e-40
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM3D,Protein FAM3D,2124,60,2.33 [1.75-3.11],6.4964993287074755e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAS,Tumor necrosis factor receptor superfamily member 6,2485,84,2.61 [2.02-3.37],2.3069133430008297e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FBLN2,Fibulin-2,2130,58,9.52 [5.45-16.61],2.1949981276139718e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,2122,60,1.74 [1.25-2.42],0.0009208932759824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,2118,60,2.56 [1.44-4.55],0.0013618419950207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCER2,Low affinity immunoglobulin epsilon Fc receptor,2467,84,2.21 [1.84-2.64],1.3127002095795877e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,2457,82,1.73 [1.14-2.60],0.0094918501944948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCRL1,Fc receptor-like protein 1,2457,82,2.02 [1.40-2.92],0.0001854686801778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCRL2,Fc receptor-like protein 2,2481,83,2.06 [1.58-2.67],7.925094338844031e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCRL6,Fc receptor-like protein 6,2461,84,1.83 [1.38-2.43],2.836144250522176e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCRLB,Fc receptor-like B,2383,81,1.57 [1.16-2.14],0.0038463761912625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FDX1,"Adrenodoxin, mitochondrial",2060,56,1.91 [1.51-2.43],9.040733304851504e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGA,Fibrinogen alpha chain,2082,59,2.64 [1.29-5.38],0.0076006315269153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF19,Fibroblast growth factor 19,2472,83,1.39 [1.10-1.75],0.0059897058420506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF21,Fibroblast growth factor 21,2472,84,1.43 [1.24-1.65],6.583749757207747e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF23,Fibroblast growth factor 23,2467,84,2.07 [1.73-2.47],1.0873321023263724e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF5,Fibroblast growth factor 5,2404,82,3.89 [2.78-5.44],2.2658057140830786e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGFBP1,Fibroblast growth factor-binding protein 1,2456,83,0.50 [0.33-0.77],0.001714310431535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGFBP2,Fibroblast growth factor-binding protein 2,2130,58,0.45 [0.27-0.73],0.0015026649964978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGFR2,Fibroblast growth factor receptor 2,2456,83,6.81 [4.32-10.73],1.5292308544508586e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGL1,Fibrinogen-like protein 1,2130,61,2.23 [1.59-3.11],2.6772388491286755e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FHIT,Bis(5'-adenosyl)-triphosphatase,2393,81,0.64 [0.48-0.84],0.0014928456183274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,2437,83,20.25 [10.98-37.37],6.3305950545690935e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FLT1,Vascular endothelial growth factor receptor 1,2437,83,2.73 [1.92-3.89],2.7106895372466548e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FNDC1,Fibronectin type III domain-containing protein 1,2116,60,3.32 [2.06-5.35],8.119954865598604e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOLR1,Folate receptor alpha,2447,83,12.35 [7.98-19.10],1.3580111105175153e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOLR2,Folate receptor beta,2476,84,9.29 [5.34-16.14],2.75848676180351e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FSTL1,Follistatin-related protein 1,2059,54,22.15 [9.22-53.23],4.381095712616292e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FSTL3,Follistatin-related protein 3,2460,83,11.54 [8.29-16.07],1.7392361844183334e-47
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,2476,84,2.55 [1.73-3.76],2.586506841881043e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FZD8,Frizzled-8,2061,56,1.81 [1.26-2.61],0.0014920847410461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GABARAP,Gamma-aminobutyric acid receptor-associated protein,2117,60,1.93 [1.37-2.70],0.000138414141116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAS6,Growth arrest-specific protein 6,2477,84,14.35 [7.15-28.81],6.891697417306674e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAST,Gastrin,2116,60,1.32 [1.15-1.51],5.5202893334139767e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GCG,Pro-glucagon,2383,81,1.52 [1.31-1.76],5.488963601937888e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,2025,53,1.98 [1.46-2.70],1.41155252257463e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",2439,83,4.07 [2.45-6.76],6.108256242703865e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GDF15,Growth/differentiation factor 15,2490,84,3.57 [2.95-4.33],1.3369467723842383e-38
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GDNF,Glial cell line-derived neurotrophic factor,2393,81,2.26 [1.44-3.55],0.0003967019475616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFRA1,GDNF family receptor alpha-1,2472,84,23.72 [15.71-35.81],2.6500489999950366e-51
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFRA2,GDNF family receptor alpha-2,2439,83,11.17 [4.73-26.38],3.642428875500115e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFRA3,GDNF family receptor alpha-3,2434,83,9.89 [6.03-16.22],1.0422280576963992e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GGT5,Glutathione hydrolase 5 proenzyme,2437,83,11.52 [6.81-19.48],7.696282972554487e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GHRL,Appetite-regulating hormone,2457,82,1.51 [1.20-1.89],0.0004926817228899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIGYF2,GRB10-interacting GYF protein 2,2118,60,1.51 [1.12-2.04],0.0071730810228625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIPC2,PDZ domain-containing protein GIPC2,2116,60,9.07 [5.55-14.81],1.249482193982204e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GM2A,Ganglioside GM2 activator,2085,58,6.92 [4.86-9.86],9.893704774942863e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GMPR,GMP reductase 1,2490,84,0.61 [0.43-0.88],0.0072823799573789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GNPDA2,Glucosamine-6-phosphate isomerase 2,2085,56,0.33 [0.18-0.62],0.000529466940613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GOLM2,Protein GOLM2,2476,84,2.29 [1.57-3.34],1.6344654388807486e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPC1,Glypican-1,2475,84,13.49 [7.54-24.11],1.6828427728408053e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPHA2,Glycoprotein hormone alpha-2,2124,60,2.00 [1.45-2.75],2.2240757518146223e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,2124,60,2.59 [1.68-4.00],1.7469984177096114e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPKOW,G-patch domain and KOW motifs-containing protein,2393,81,1.62 [1.12-2.34],0.0097975365532353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPNMB,Transmembrane glycoprotein NMB,2400,80,6.55 [3.49-12.31],5.220232862046384e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPR158,Probable G-protein coupled receptor 158,2118,60,2.88 [1.88-4.42],1.331401251954969e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPR37,Prosaposin receptor GPR37,2415,83,4.60 [3.54-5.98],5.1113343459180735e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPRC5C,G-protein coupled receptor family C group 5 member C,2117,60,1.82 [1.31-2.54],0.0003994216408545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRN,Progranulin,2453,84,11.45 [6.61-19.81],3.048872748224205e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRP,Gastrin-releasing peptide,2059,54,2.50 [1.57-3.97],0.000114839984001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRPEL1,"GrpE protein homolog 1, mitochondrial",2439,83,1.95 [1.52-2.50],1.3423417617878477e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GUCA2A,Guanylin,2455,84,7.09 [5.23-9.60],1.2353381681830524e-36
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GZMA,Granzyme A,2490,84,2.75 [1.60-4.71],0.0002337100213049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",2470,84,0.66 [0.50-0.87],0.0028953108277227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,2473,84,3.32 [2.85-3.87],9.81863014927756e-53
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HAVCR2,Hepatitis A virus cellular receptor 2,2467,84,9.42 [6.71-13.23],2.896187214364276e-38
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HBQ1,Hemoglobin subunit theta-1,2475,84,0.52 [0.37-0.73],0.0001347199004677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HBZ,Hemoglobin subunit zeta,2122,60,0.69 [0.53-0.89],0.0044079983655143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HEPH,Hephaestin,2122,60,16.76 [6.51-43.18],5.245472711904775e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HIP1R,Huntingtin-interacting protein 1-related protein,2114,60,1.71 [1.45-2.01],7.817811126514116e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HJV,Hemojuvelin,2118,60,2.10 [1.42-3.09],0.0001796613401166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",2118,60,4.34 [2.02-9.35],0.0001762871402983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",2461,84,5.20 [3.89-6.94],6.283149746609944e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HMBS,Porphobilinogen deaminase,2475,84,0.40 [0.25-0.62],3.817365081681965e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HMCN2,Hemicentin-2,2082,55,2.01 [1.29-3.13],0.0021826117106915
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HMOX2,Heme oxygenase 2,2393,81,1.63 [1.21-2.19],0.0012388820577475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HNMT,Histamine N-methyltransferase,2426,82,2.86 [2.12-3.86],5.712676088466858e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HPGDS,Hematopoietic prostaglandin D synthase,2383,81,0.35 [0.20-0.60],0.0001447537295267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,2059,54,6.08 [3.80-9.73],4.794607153749855e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,2439,83,2.52 [1.57-4.03],0.0001156456753966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,2475,84,2.04 [1.48-2.81],1.4074240076585876e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,2062,59,3.87 [2.66-5.64],1.689539129211869e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSPA2,Heat shock-related 70 kDa protein 2,2117,60,3.44 [2.47-4.80],3.3891437233291e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSPB6,Heat shock protein beta-6,2475,84,5.05 [3.66-6.98],8.726242945737917e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,2443,83,8.74 [6.14-12.44],2.529388453302573e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HYAL1,Hyaluronidase-1,2441,81,2.89 [1.49-5.58],0.0016300024348784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HYOU1,Hypoxia up-regulated protein 1,2490,84,37.44 [19.90-70.44],2.675340050108729e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ICAM1,Intercellular adhesion molecule 1,2448,83,2.12 [1.21-3.73],0.0087550722830223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ICAM2,Intercellular adhesion molecule 2,2490,84,5.49 [2.97-10.12],5.034023145732299e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ICAM3,Intercellular adhesion molecule 3,2490,84,2.87 [1.52-5.41],0.0011204636268339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ICOSLG,ICOS ligand,2439,83,8.52 [3.18-22.78],1.9853412528738984e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IDI2,Isopentenyl-diphosphate delta-isomerase 2,2393,81,1.62 [1.23-2.14],0.0005319262140799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,2068,58,4.37 [2.65-7.22],8.155033239109002e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNAR1,Interferon alpha/beta receptor 1,2124,60,2.62 [1.31-5.24],0.0065055331361858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNG,Interferon gamma,2404,82,1.45 [1.23-1.71],1.2728827182205149e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNGR1,Interferon gamma receptor 1,2472,83,31.67 [17.75-56.51],1.373115579907106e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNL1,Interferon lambda-1,2393,81,1.62 [1.23-2.13],0.0006626834070481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGF1R,Insulin-like growth factor 1 receptor,2439,83,12.42 [7.59-20.31],1.0594158220808864e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP1,Insulin-like growth factor-binding protein 1,2488,84,1.70 [1.46-1.97],5.927910150686537e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP2,Insulin-like growth factor-binding protein 2,2485,84,3.38 [2.63-4.34],1.4659018002559549e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP4,Insulin-like growth factor-binding protein 4,2439,82,5.12 [4.13-6.35],8.274711663461119e-50
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP6,Insulin-like growth factor-binding protein 6,2449,82,5.88 [4.39-7.87],1.6626217359120695e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP7,Insulin-like growth factor-binding protein 7,2490,84,4.06 [3.04-5.42],2.41621353272686e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBPL1,Insulin-like growth factor-binding protein-like 1,2457,82,4.09 [2.86-5.87],1.790251549444744e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGLC2,Immunoglobulin lambda constant 2,2121,59,3.76 [2.34-6.04],4.224428055866578e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGSF3,Immunoglobulin superfamily member 3,2439,83,2.00 [1.43-2.79],5.011118978369487e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGSF8,Immunoglobulin superfamily member 8,2457,82,3.11 [2.31-4.18],6.202919918401935e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL10,Interleukin-10,2404,82,1.39 [1.13-1.69],0.0013502942066918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL10RB,Interleukin-10 receptor subunit beta,2472,83,17.16 [10.67-27.60],9.101681078428171e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL12A_IL12B,Interleukin-12,2439,83,2.03 [1.67-2.46],1.5941518608371346e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL12B,Interleukin-12 subunit beta,2490,84,2.75 [2.02-3.76],1.6496539722207574e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL12RB1,Interleukin-12 receptor subunit beta-1,2404,82,5.05 [3.40-7.52],1.3451957392809373e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL15,Interleukin-15,2461,84,2.57 [1.52-4.35],0.0004275886887062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL15RA,Interleukin-15 receptor subunit alpha,2404,82,6.23 [4.36-8.90],7.820456264589185e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL16,Pro-interleukin-16,2490,84,2.15 [1.65-2.81],2.0630048260617336e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL17A,Interleukin-17A,2399,81,1.71 [1.26-2.32],0.0005708954965127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL17C,Interleukin-17C,2404,82,2.15 [1.83-2.53],9.293302140101288e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL17D,Interleukin-17D,2404,82,1.82 [1.34-2.48],0.0001177269783349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL17RB,Interleukin-17 receptor B,2436,84,1.59 [1.12-2.25],0.009490169650473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL18,Interleukin-18,2454,83,2.39 [1.62-3.55],1.3297438212094754e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL18BP,Interleukin-18-binding protein,2464,83,11.10 [7.43-16.59],7.990186803371418e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL18R1,Interleukin-18 receptor 1,2490,84,4.19 [2.57-6.82],8.524460070610442e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL19,Interleukin-19,2402,80,1.50 [1.26-1.78],4.146695879756547e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1R1,Interleukin-1 receptor type 1,2464,84,16.58 [9.67-28.45],1.978265798173158e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1RL1,Interleukin-1 receptor-like 1,2485,84,2.58 [1.67-3.98],1.7889323334157e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1RN,Interleukin-1 receptor antagonist protein,2454,83,1.52 [1.15-2.00],0.0030748396007541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL22,Interleukin-22,2117,60,1.52 [1.11-2.07],0.0085441939903738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL2RA,Interleukin-2 receptor subunit alpha,2444,83,4.06 [3.12-5.29],2.5359833325174348e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL2RB,Interleukin-2 receptor subunit beta,2404,82,1.71 [1.14-2.56],0.0092292369679782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL2RG,Cytokine receptor common subunit gamma,2117,60,2.62 [1.68-4.09],2.0622788182482887e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL32,Interleukin-32,2461,84,1.54 [1.14-2.07],0.0050534344181808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL33,Interleukin-33,2404,82,1.91 [1.21-3.01],0.0053160473935588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL4R,Interleukin-4 receptor subunit alpha,2461,84,7.02 [4.88-10.08],6.586400134017461e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL5RA,Interleukin-5 receptor subunit alpha,2461,84,1.90 [1.42-2.55],1.6835687261452664e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL6,Interleukin-6,2439,83,1.32 [1.11-1.57],0.0018531122709415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL6R,Interleukin-6 receptor subunit alpha,2445,83,3.19 [1.84-5.54],3.663506513378848e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL6ST,Interleukin-6 receptor subunit beta,2457,82,11.86 [4.58-30.72],3.5095155607032685e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IMMT,MICOS complex subunit MIC60,2117,60,2.94 [2.02-4.26],1.4600649022306153e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INHBB,Inhibin beta B chain,2085,56,4.74 [3.28-6.86],1.3190637251078646e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INHBC,Inhibin beta C chain,2467,84,2.12 [1.22-3.68],0.0073167243770962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INSL4,Early placenta insulin-like peptide,2117,60,2.86 [2.19-3.74],1.6182579934897174e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INSL5,Insulin-like peptide INSL5,2124,60,1.58 [1.27-1.97],3.693231646326748e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INSR,Insulin receptor,2062,59,8.89 [2.78-28.45],0.0002330706334354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ISM1,Isthmin-1,2461,84,1.78 [1.32-2.39],0.0001655213301413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGAL,Integrin alpha-L,2062,59,2.17 [1.23-3.84],0.0078888246345506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGB2,Integrin beta-2,2458,82,2.53 [1.43-4.48],0.0014621292911247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGB6,Integrin beta-6,2404,82,8.27 [4.60-14.85],1.5316470937586434e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGB7,Integrin beta-7,2475,84,1.73 [1.20-2.49],0.0033460027006458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGBL1,Integrin beta-like protein 1,2130,58,2.98 [2.10-4.24],1.155251985359773e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,2464,83,4.71 [2.82-7.86],3.0420389521294438e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITM2A,Integral membrane protein 2A,2461,84,1.90 [1.43-2.51],7.566056386544767e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",JAM2,Junctional adhesion molecule B,2476,84,16.09 [11.14-23.23],1.2110951897967149e-49
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",JAM3,Junctional adhesion molecule C,2085,56,1.80 [1.32-2.45],0.000180744546905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",JCHAIN,Immunoglobulin J chain,2404,82,1.73 [1.28-2.33],0.0003517548473883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",JUN,Transcription factor AP-1,2404,82,1.55 [1.25-1.93],8.646292275837253e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,2439,83,4.09 [2.70-6.17],2.3150579011595315e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIAA0319,Dyslexia-associated protein KIAA0319,2116,60,5.31 [3.38-8.34],3.9959104766457097e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIF1C,Kinesin-like protein KIF1C,2060,56,2.64 [1.49-4.68],0.0008914734918939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,2383,81,1.49 [1.18-1.87],0.0007157533713403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIRREL2,Kin of IRRE-like protein 2,2393,81,3.69 [2.52-5.40],2.068257552449983e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KITLG,Kit ligand,2457,82,3.44 [2.13-5.53],3.770199699216556e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLB,Beta-klotho,2393,81,1.40 [1.10-1.78],0.005753880720999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLHL41,Kelch-like protein 41,2118,60,1.63 [1.25-2.13],0.0002656350706124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK10,Kallikrein-10,2450,83,2.38 [1.62-3.50],9.330556277021371e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK11,Kallikrein-11,2432,83,13.11 [8.74-19.67],1.8899949759584884e-35
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK14,Kallikrein-14,2475,84,2.75 [1.89-4.02],1.5421701247424226e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK15,Kallikrein-15,2111,60,1.96 [1.19-3.22],0.0085265188741373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK4,Kallikrein-4,2475,84,2.59 [2.17-3.09],1.3899716986305402e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK6,Kallikrein-6,2452,83,7.32 [4.72-11.37],7.067675751880716e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK8,Kallikrein-8,2361,80,4.81 [3.40-6.79],6.246089465896043e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLRB1,Killer cell lectin-like receptor subfamily B member 1,2490,84,9.86 [6.97-13.97],4.660948973448478e-38
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLRD1,Natural killer cells antigen CD94,2490,84,3.68 [2.53-5.37],1.1090465417003587e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLRF1,Killer cell lectin-like receptor subfamily F member 1,2062,59,1.72 [1.33-2.23],3.380806908855977e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLRK1,NKG2-D type II integral membrane protein,2116,60,4.01 [2.94-5.47],2.2433049871065004e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KRT18,"Keratin, type I cytoskeletal 18",2439,83,1.27 [1.07-1.51],0.0075617582157207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KRT19,"Keratin, type I cytoskeletal 19",2458,84,2.50 [2.04-3.08],3.7794057863380826e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KRT8,"Keratin, type II cytoskeletal 8",2061,56,1.24 [1.07-1.44],0.0053264323494418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KYAT1,Kynurenine--oxoglutarate transaminase 1,2456,82,0.57 [0.40-0.82],0.0024124967702512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAG3,Lymphocyte activation gene 3 protein,2439,83,2.38 [1.90-2.99],6.186232503977481e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,2462,83,4.73 [3.74-5.99],1.7733701168545134e-38
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,2437,83,1.55 [1.27-1.89],1.6980199944530056e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAMA4,Laminin subunit alpha-4,2472,83,4.03 [2.55-6.36],2.1480692638285674e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAMB1,Laminin subunit beta-1,2059,54,5.03 [2.23-11.36],9.947059192134094e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAMP3,Lysosome-associated membrane glycoprotein 3,2484,84,2.40 [1.69-3.40],8.924277553906093e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAYN,Layilin,2433,83,8.07 [6.18-10.56],1.1735097850927293e-52
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LBP,Lipopolysaccharide-binding protein,2464,83,2.17 [1.57-3.00],2.470182714664468e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LCN15,Lipocalin-15,2118,60,1.68 [1.37-2.06],6.471144992301611e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LCN2,Neutrophil gelatinase-associated lipocalin,2381,79,3.61 [2.75-4.73],2.3596420120665896e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LECT2,Leukocyte cell-derived chemotaxin-2,2122,60,1.64 [1.25-2.15],0.0003275271345438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LEFTY2,Left-right determination factor 2,2472,84,1.88 [1.32-2.68],0.0005223688771008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LEPR,Leptin receptor,2457,82,2.09 [1.20-3.65],0.0094775154933735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LETM1,Mitochondrial proton/calcium exchanger protein,2118,60,1.82 [1.29-2.56],0.0006392401949515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS1,Galectin-1,2457,82,3.82 [2.49-5.85],7.99253681341638e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS3,Galectin-3,2463,83,5.36 [3.12-9.21],1.1557332743717207e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS4,Galectin-4,2462,83,3.42 [2.70-4.33],2.7237329162016905e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS7_LGALS7B,Galectin-7,2449,83,3.28 [2.42-4.44],1.54053085782537e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS9,Galectin-9,2466,83,14.04 [8.54-23.08],2.154988524478967e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGMN,Legumain,2472,83,1.95 [1.18-3.20],0.0086012565476357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,2459,83,0.67 [0.52-0.88],0.0034124840040935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LIFR,Leukemia inhibitory factor receptor,2461,84,13.58 [7.46-24.70],1.3157038513598317e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,2457,82,6.56 [3.68-11.67],1.6345956941633355e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,2480,84,3.27 [1.91-5.58],1.4434506594680548e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,2404,82,5.04 [3.58-7.11],2.62486409047732e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LMNB2,Lamin-B2,2116,60,5.28 [3.52-7.94],1.084533990790027e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LMOD1,Leiomodin-1,2118,60,4.93 [3.55-6.86],2.2357788752581235e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRG1,Leucine-rich alpha-2-glycoprotein,2126,59,8.66 [3.92-19.14],9.544348192714613e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,2470,84,3.49 [2.37-5.14],2.795253080541057e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRP11,Low-density lipoprotein receptor-related protein 11,2457,82,10.07 [6.78-14.97],3.290567191397459e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRRC25,Leucine-rich repeat-containing protein 25,2439,83,1.77 [1.39-2.26],3.4372218423794235e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRRC37A2,Leucine-rich repeat-containing protein 37A2,2124,60,2.18 [1.24-3.84],0.006664120631825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LSP1,Lymphocyte-specific protein 1,2461,84,2.06 [1.32-3.20],0.0014403267931779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LTBP2,Latent-transforming growth factor beta-binding protein 2,2490,84,6.87 [4.82-9.79],1.5757055201705926e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LTBP3,Latent-transforming growth factor beta-binding protein 3,2383,81,1.64 [1.33-2.02],2.7852860278337545e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LTBR,Tumor necrosis factor receptor superfamily member 3,2450,83,10.76 [7.64-15.15],3.586509563905629e-42
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LUZP2,Leucine zipper protein 2,2117,60,2.22 [1.63-3.01],3.548880655396277e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LXN,Latexin,2424,83,0.57 [0.41-0.78],0.0004164711247225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LY6D,Lymphocyte antigen 6D,2447,83,4.08 [3.14-5.30],5.329494072287669e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LY75,Lymphocyte antigen 75,2461,84,2.01 [1.22-3.29],0.0057502605952329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LY9,T-lymphocyte surface antigen Ly-9,2424,81,2.93 [1.63-5.27],0.0003216641556909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYPD8,Ly6/PLAUR domain-containing protein 8,2383,81,1.37 [1.12-1.68],0.0024065912662419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,2126,59,6.35 [1.96-20.61],0.0020720341717977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYZL2,Lysozyme-like protein 2,2044,59,2.19 [1.21-3.97],0.0098745126369245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,2425,83,1.63 [1.34-1.99],1.3307604899755443e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAMDC2,MAM domain-containing protein 2,2122,60,6.80 [4.25-10.88],1.3146190947691484e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",2059,54,5.75 [2.03-16.28],0.0009866029846924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MANSC1,MANSC domain-containing protein 1,2456,83,17.28 [9.94-30.04],5.662999591827509e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MATN2,Matrilin-2,2467,83,7.13 [3.85-13.18],3.8395882252683287e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MB,Myoglobin,2490,84,2.21 [1.76-2.77],7.728465901701186e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MCAM,Cell surface glycoprotein MUC18,2464,83,2.56 [1.64-3.98],3.428349538641319e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MCFD2,Multiple coagulation factor deficiency protein 2,2444,82,1.98 [1.33-2.95],0.0007756677445155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,2437,83,1.50 [1.14-1.98],0.0035012352176914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MDK,Midkine,2447,83,2.11 [1.69-2.64],5.505981457552871e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MELTF,Melanotransferrin,2122,60,6.28 [2.90-13.62],3.2514531906282184e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MEP1B,Meprin A subunit beta,2457,82,0.80 [0.68-0.94],0.0052651561234655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MEPE,Matrix extracellular phosphoglycoprotein,2462,83,3.92 [1.75-8.78],0.000879675701589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MERTK,Tyrosine-protein kinase Mer,2490,84,5.27 [2.83-9.80],1.5683455210268128e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MFAP4,Microfibril-associated glycoprotein 4,2085,56,5.57 [2.82-11.03],8.046820321160222e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MFAP5,Microfibrillar-associated protein 5,2490,84,6.91 [4.59-10.39],1.654241967799467e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MIA,Melanoma-derived growth regulatory protein,2456,83,3.76 [2.46-5.74],9.794337681077419e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,2461,84,1.33 [1.09-1.63],0.0059745738931637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MILR1,Allergin-1,2404,82,1.98 [1.40-2.82],0.0001285185458896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MLN,Promotilin,2461,84,1.46 [1.17-1.84],0.0010232397893842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP1,Interstitial collagenase,2387,82,1.42 [1.13-1.78],0.0024513324822995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP10,Stromelysin-2,2457,83,3.15 [2.37-4.20],4.261897245459378e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP12,Macrophage metalloelastase,2459,84,2.48 [1.91-3.23],1.3963908994030319e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP3,Stromelysin-1,2467,84,2.61 [1.95-3.49],8.970017459842863e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP7,Matrilysin,2412,83,7.39 [5.20-10.51],7.582992474482077e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MOG,Myelin-oligodendrocyte glycoprotein,2475,84,5.94 [3.95-8.93],1.0816855933413978e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MRC1,Macrophage mannose receptor 1,2130,61,5.74 [2.64-12.46],1.0155712075013735e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MSLN,Mesothelin,2434,83,1.96 [1.48-2.60],2.6573026873885925e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MSMB,Beta-microseminoprotein,2459,82,2.44 [1.95-3.05],5.814628275809317e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MSR1,Macrophage scavenger receptor types I and II,2476,84,2.96 [2.05-4.28],7.277016545219643e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MSTN,Growth/differentiation factor 8,2415,83,1.87 [1.32-2.64],0.0004074680434774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MUC13,Mucin-13,2393,81,2.14 [1.64-2.79],2.3232500277029752e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MXRA8,Matrix remodeling-associated protein 8,2085,56,4.64 [2.19-9.86],6.412637431124757e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYBPC1,"Myosin-binding protein C, slow-type",2122,60,1.68 [1.30-2.16],5.383310079923845e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYBPC2,"Myosin-binding protein C, fast-type",2059,54,1.42 [1.17-1.73],0.0003476618637755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYH7B,Myosin-7B,2044,59,2.09 [1.29-3.37],0.0025405230768145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",2060,56,1.57 [1.20-2.05],0.0009438204863903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYL3,Myosin light chain 3,2059,54,1.60 [1.17-2.20],0.0036834976874455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",2076,58,1.78 [1.37-2.30],1.3796959522103107e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYO6,Unconventional myosin-VI,2118,60,1.90 [1.28-2.82],0.001511589945836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYOC,Myocilin,2467,84,2.05 [1.35-3.09],0.0006673635622366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYOM2,Myomesin-2,2060,56,1.53 [1.12-2.08],0.0074409889219884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MZB1,Marginal zone B- and B1-cell-specific protein,2468,83,2.25 [1.62-3.13],1.231321470179497e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAGK,N-acetyl-D-glucosamine kinase,2056,54,0.46 [0.30-0.73],0.0009088651955687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAP1L4,Nucleosome assembly protein 1-like 4,2120,59,0.44 [0.24-0.79],0.0064013886217966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NBL1,Neuroblastoma suppressor of tumorigenicity 1,2456,83,27.06 [16.97-43.15],1.2142584239725264e-43
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCR1,Natural cytotoxicity triggering receptor 1,2458,84,7.22 [5.25-9.91],3.112441539356228e-34
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,2124,60,10.52 [6.55-16.91],2.438381231014744e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCS1,Neuronal calcium sensor 1,2475,84,9.74 [5.58-17.01],1.2253193035739382e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,2059,59,2.57 [1.33-4.94],0.0047350018692964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",2383,81,1.54 [1.31-1.82],2.646627193717883e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NECTIN2,Nectin-2,2457,82,12.53 [8.58-18.32],5.7187938956861415e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NECTIN4,Nectin-4,2456,83,6.20 [4.71-8.15],5.856401120072636e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NEFL,Neurofilament light polypeptide,2385,80,3.11 [2.59-3.74],1.4143408986581446e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NELL1,Protein kinase C-binding protein NELL1,2456,83,0.33 [0.25-0.45],8.13183821999557e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NEO1,Neogenin,2118,60,3.26 [2.08-5.10],2.3963562488852295e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFASC,Neurofascin,2490,84,6.55 [3.87-11.11],2.834311714179379e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NGF,Beta-nerve growth factor,2437,83,6.17 [2.19-17.39],0.0005754084571593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NGRN,Neugrin,2116,60,5.46 [2.36-12.63],7.34731835564207e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NHLRC3,NHL repeat-containing protein 3,2038,53,4.64 [2.00-10.72],0.0003350268210663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NIT1,Deaminated glutathione amidase,2059,54,0.38 [0.23-0.64],0.0002073942354222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOS1,"Nitric oxide synthase, brain",2393,81,2.39 [1.92-2.98],8.300892162905591e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOTCH1,Neurogenic locus notch homolog protein 1,2490,84,28.45 [9.76-82.93],8.647522223355991e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOTCH2,Neurogenic locus notch homolog protein 2,2130,58,10.56 [4.88-22.85],2.206495483948188e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOTCH3,Neurogenic locus notch homolog protein 3,2490,84,4.49 [2.77-7.25],9.255069490726595e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPC2,NPC intracellular cholesterol transporter 2,2096,58,16.51 [10.07-27.06],1.038918625192978e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPDC1,Neural proliferation differentiation and control protein 1,2457,82,7.01 [5.18-9.48],1.0840043158626776e-36
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPHS1,Nephrin,2062,59,0.31 [0.15-0.62],0.0009108936907283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPPB,Natriuretic peptides B,2415,83,1.42 [1.26-1.60],9.362961401432626e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPPC,C-type natriuretic peptide,2461,84,2.11 [1.68-2.65],1.902437397669909e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPY,Pro-neuropeptide Y,2475,84,2.45 [1.78-3.39],5.247062119138904e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NRCAM,Neuronal cell adhesion molecule,2457,82,3.09 [1.80-5.31],4.191159334045334e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NRP1,Neuropilin-1,2466,83,6.91 [3.78-12.62],3.3181379950389433e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NT5C1A,Cytosolic 5'-nucleotidase 1A,2116,60,3.52 [2.58-4.79],1.3663813342514965e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NT5C3A,Cytosolic 5'-nucleotidase 3A,2457,84,0.74 [0.59-0.93],0.0085680282213281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NTF3,Neurotrophin-3,2461,84,2.01 [1.35-2.99],0.0005524182871218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NTproBNP,N-terminal prohormone of brain natriuretic peptide,2457,82,1.58 [1.41-1.76],6.030859000600214e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUCB2,Nucleobindin-2,2471,84,4.37 [2.87-6.66],6.434217607232808e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NXPH1,Neurexophilin-1,2393,81,2.40 [1.70-3.39],7.476307089819468e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NXPH3,Neurexophilin-3,2062,59,12.05 [6.12-23.75],6.374512981997027e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OCLN,Occludin,2118,60,5.58 [3.89-8.00],1.0601885378179312e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OGFR,Opioid growth factor receptor,2439,83,3.52 [2.12-5.85],1.2035554209188354e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OGN,Mimecan,2467,84,6.17 [4.70-8.10],2.6507139948389013e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OPTC,Opticin,2439,83,1.73 [1.30-2.30],0.0001633489239279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ORM1,Alpha-1-acid glycoprotein 1,2120,59,5.47 [2.04-14.70],0.000750308341892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OSCAR,Osteoclast-associated immunoglobulin-like receptor,2467,83,7.50 [4.55-12.37],2.938942517752655e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OSMR,Oncostatin-M-specific receptor subunit beta,2466,83,3.71 [1.59-8.63],0.0023852197774678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",P4HB,Protein disulfide-isomerase,2439,82,2.40 [1.46-3.95],0.0005444390068065
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PALM,Paralemmin-1,2113,59,12.93 [7.79-21.44],3.5906570807040203e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PALM2,Paralemmin-2,2116,60,6.57 [4.70-9.18],2.607842879476782e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAM,Peptidyl-glycine alpha-amidating monooxygenase,2479,84,16.04 [7.92-32.49],1.2797180182560476e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,2124,60,5.62 [3.47-9.08],1.866973580097732e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCDH1,Protocadherin-1,2476,84,5.99 [3.20-11.20],2.152506731131882e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCDH17,Protocadherin-17,2457,82,2.02 [1.32-3.10],0.0012242279369853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCDH7,Protocadherin-7,2124,60,3.86 [2.60-5.73],2.0531594544316368e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCDHB15,Protocadherin beta-15,2117,60,3.44 [2.10-5.64],9.703169708382937e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCSK9,Proprotein convertase subtilisin/kexin type 9,2490,84,2.34 [1.47-3.74],0.0003655833893775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDCD1,Programmed cell death protein 1,2472,84,3.15 [2.30-4.32],8.829581993004e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDCD1LG2,Programmed cell death 1 ligand 2,2439,83,6.03 [4.34-8.37],8.99059433872123e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDGFRA,Platelet-derived growth factor receptor alpha,2457,82,5.87 [3.63-9.48],5.277227055433629e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDIA3,Protein disulfide-isomerase A3,2085,56,4.20 [2.10-8.40],5.162587405547917e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,2062,59,1.86 [1.27-2.72],0.001530597132076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PEAR1,Platelet endothelial aggregation receptor 1,2490,84,6.56 [2.91-14.78],5.757204584317725e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PENK,Proenkephalin-A,2085,56,7.05 [4.52-11.01],7.783679866394576e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGA4,Pepsin A-4,2130,61,1.83 [1.42-2.36],2.606266797404952e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGF,Placenta growth factor,2490,84,13.14 [8.77-19.70],9.133299147839252e-36
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGLYRP1,Peptidoglycan recognition protein 1,2480,84,2.92 [2.15-3.96],5.8255461765882265e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PHLDB1,Pleckstrin homology-like domain family B member 1,2124,60,4.40 [3.10-6.24],1.0407755257877202e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,2437,83,8.65 [5.31-14.08],4.315286912919467e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PI16,Peptidase inhibitor 16,2130,61,27.69 [10.63-72.10],1.0433400039907942e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PI3,Elafin,2427,83,2.15 [1.79-2.58],5.395604271393408e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PIGR,Polymeric immunoglobulin receptor,2433,83,3.34 [2.35-4.75],1.9754696253520143e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,2467,84,14.55 [10.44-20.27],2.083175504047367e-56
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PILRA,Paired immunoglobulin-like type 2 receptor alpha,2467,84,7.49 [4.91-11.43],8.956067711589117e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PILRB,Paired immunoglobulin-like type 2 receptor beta,2457,82,4.58 [3.09-6.80],3.519437737651388e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PKD1,Polycystin-1,2122,60,7.35 [3.28-16.48],1.2600378509917025e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PKD2,Polycystin-2,2060,56,1.63 [1.13-2.36],0.0089387902024405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLA2G10,Group 10 secretory phospholipase A2,2437,83,2.06 [1.47-2.88],2.4321019454551952e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLA2G1B,Phospholipase A2,2488,84,1.72 [1.21-2.44],0.0023442361903551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLA2G2A,"Phospholipase A2, membrane associated",2455,80,1.41 [1.10-1.82],0.0072840168558157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLA2G7,Platelet-activating factor acetylhydrolase,2467,84,0.37 [0.23-0.58],2.3263660115402143e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLAU,Urokinase-type plasminogen activator,2467,84,1.97 [1.20-3.26],0.0078990948280451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLAUR,Urokinase plasminogen activator surface receptor,2450,83,11.95 [7.76-18.41],1.8824589666519226e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLIN3,Perilipin-3,2457,82,2.32 [1.59-3.40],1.530816611099007e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLPBP,Pyridoxal phosphate homeostasis protein,2457,82,0.67 [0.49-0.91],0.0093262575206682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLXDC1,Plexin domain-containing protein 1,2383,81,1.91 [1.23-2.95],0.0036732275849774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLXNB2,Plexin-B2,2482,83,5.96 [3.64-9.75],1.3005119700731386e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PNLIPRP1,Inactive pancreatic lipase-related protein 1,2116,60,1.59 [1.24-2.05],0.0002568668378323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PODXL2,Podocalyxin-like protein 2,2456,83,6.68 [3.74-11.92],1.285356035862742e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",POF1B,Protein POF1B,2062,59,2.40 [1.69-3.43],1.206496313835234e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",2439,83,2.22 [1.70-2.90],5.178362986377198e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PON1,Serum paraoxonase/arylesterase 1,2130,61,0.27 [0.14-0.54],0.0002151396855852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPL,Periplakin,2062,59,4.50 [2.64-7.67],3.029396692016904e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,2118,60,2.85 [2.10-3.87],1.585701902229824e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPY,Pancreatic prohormone,2444,80,1.53 [1.29-1.82],1.0933599733655192e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRAP1,Proline-rich acidic protein 1,2130,58,12.73 [6.25-25.92],2.3227199976314697e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRCP,Lysosomal Pro-X carboxypeptidase,2476,84,2.71 [1.67-4.40],5.6285354339033525e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRDX2,Peroxiredoxin-2,2099,61,0.48 [0.31-0.74],0.0008431012685795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRDX6,Peroxiredoxin-6,2475,84,0.59 [0.42-0.83],0.0021691002364753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PREB,Prolactin regulatory element-binding protein,2404,82,2.82 [1.97-4.06],1.869756919973659e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRELP,Prolargin,2462,83,8.09 [4.70-13.93],4.8030202296865953e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRG2,Bone marrow proteoglycan,2130,58,4.41 [3.00-6.47],3.54604293662462e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRG3,Proteoglycan 3,2130,58,1.99 [1.23-3.22],0.0052402889531845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRND,Prion-like protein doppel,2116,60,3.00 [2.06-4.37],9.935998482270348e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRR4,Proline-rich protein 4,2068,56,1.60 [1.17-2.18],0.0028933697574747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRRT3,Proline-rich transmembrane protein 3,2059,54,5.53 [3.66-8.36],5.1017542553404165e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRSS2,Trypsin-2,2464,83,1.81 [1.47-2.23],2.7574780077352978e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRSS22,Brain-specific serine protease 4,2062,59,2.39 [1.68-3.39],1.092598994191678e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRSS27,Serine protease 27,2452,82,3.45 [2.19-5.42],8.314229464435179e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRSS8,Prostasin,2451,83,5.80 [3.84-8.75],5.779233619973621e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRTG,Protogenin,2475,84,4.14 [2.01-8.50],0.0001109624231771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRTN3,Myeloblastin,2400,79,1.57 [1.15-2.14],0.004463439273593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSAP,Prosaposin,2114,58,15.11 [7.56-30.17],1.4456419296837996e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSAPL1,Proactivator polypeptide-like 1,2124,60,2.82 [2.01-3.97],2.531375918643069e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSCA,Prostate stem cell antigen,2124,60,1.18 [1.06-1.33],0.0039173919409458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSG1,Pregnancy-specific beta-1-glycoprotein 1,2437,83,1.32 [1.09-1.60],0.005378155551746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSMD9,26S proteasome non-ATPase regulatory subunit 9,2439,83,0.57 [0.39-0.84],0.0043968847953533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSMG3,Proteasome assembly chaperone 3,2461,84,0.58 [0.39-0.88],0.0094342244360231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTGDS,Prostaglandin-H2 D-isomerase,2440,83,2.99 [2.04-4.39],2.1876042770027243e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTH,Parathyroid hormone,2076,58,1.60 [1.25-2.05],0.0001617751774259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,2461,84,1.88 [1.46-2.41],7.378510711372007e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTK7,Inactive tyrosine-protein kinase 7,2393,81,3.87 [2.63-5.71],8.65874100644167e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTP4A3,Protein tyrosine phosphatase type IVA 3,2062,59,1.67 [1.18-2.37],0.0040333771399601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRF,Receptor-type tyrosine-protein phosphatase F,2490,84,4.39 [2.33-8.24],4.436883320940314e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRH,Receptor-type tyrosine-protein phosphatase H,2124,60,1.73 [1.17-2.56],0.0056853447209016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,2124,60,3.59 [1.62-7.94],0.0016075338366851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,2429,83,8.71 [5.80-13.10],2.1972186913524177e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRR,Receptor-type tyrosine-protein phosphatase R,2116,60,4.28 [2.81-6.52],1.3825892764101251e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRS,Receptor-type tyrosine-protein phosphatase S,2490,84,7.64 [4.90-11.90],2.6436498837789213e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTX3,Pentraxin-related protein PTX3,2461,84,2.12 [1.29-3.47],0.0028763912873766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PVR,Poliovirus receptor,2476,84,2.13 [1.43-3.17],0.00021094810732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PXN,Paxillin,2393,81,1.52 [1.12-2.07],0.0069877203884876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PYDC1,Pyrin domain-containing protein 1,2059,54,2.07 [1.34-3.20],0.0009764320617719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PYY,Peptide YY,2060,56,1.55 [1.27-1.89],1.976511317851824e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",QPCT,Glutaminyl-peptide cyclotransferase,2464,84,22.29 [12.81-38.78],4.500963878202489e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",QSOX1,Sulfhydryl oxidase 1,2079,58,1.81 [1.26-2.60],0.0013292546097836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB6A,Ras-related protein Rab-6A,2461,84,0.54 [0.37-0.78],0.0009770058820065
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RALY,RNA-binding protein Raly,2117,60,1.56 [1.12-2.18],0.0088728604256775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RANBP1,Ran-specific GTPase-activating protein,2059,54,0.44 [0.26-0.75],0.0021831344062331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RARRES1,Retinoic acid receptor responder protein 1,2383,81,3.32 [2.25-4.89],1.357405302235209e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RARRES2,Retinoic acid receptor responder protein 2,2466,83,2.29 [1.77-2.98],3.799548103418652e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBFOX3,RNA binding protein fox-1 homolog 3,2118,60,7.76 [5.52-10.90],5.021716461161856e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBKS,Ribokinase,2400,82,0.49 [0.34-0.72],0.0002583726741171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBP2,Retinol-binding protein 2,2439,83,2.05 [1.71-2.45],4.5844501905727806e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBP5,Retinol-binding protein 5,2439,83,2.15 [1.63-2.84],5.172615945402629e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBP7,Retinoid-binding protein 7,2124,60,1.50 [1.12-2.01],0.0072751684903017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,2059,54,4.39 [1.46-13.16],0.0082527873890954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REG1A,Lithostathine-1-alpha,2440,82,4.12 [3.27-5.19],1.6780281437535886e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REG1B,Lithostathine-1-beta,2490,84,3.28 [2.66-4.06],3.989720977924666e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REG3A,Regenerating islet-derived protein 3-alpha,2490,84,2.85 [2.31-3.51],8.957715338664933e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REG3G,Regenerating islet-derived protein 3-gamma,2117,60,2.17 [1.28-3.67],0.0040810576366758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REG4,Regenerating islet-derived protein 4,2467,83,3.94 [2.96-5.24],4.2097640328567255e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RELT,Tumor necrosis factor receptor superfamily member 19L,2467,84,11.27 [7.89-16.09],1.405312115542229e-40
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REN,Renin,2457,82,1.78 [1.51-2.11],1.3280384913930697e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RETN,Resistin,2458,82,3.44 [2.55-4.65],8.830101336253955e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RGMA,Repulsive guidance molecule A,2476,84,7.46 [4.36-12.78],2.4684850679829014e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RGMB,RGM domain family member B,2476,84,12.76 [8.27-19.68],1.1312874003466e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,2085,56,1.89 [1.28-2.80],0.0014869325133536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RLN1,Prorelaxin H1,2118,60,1.66 [1.20-2.30],0.0023934653633845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RLN2,Prorelaxin H2,2080,56,1.64 [1.19-2.25],0.0023984196832145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASE1,Ribonuclease pancreatic,2130,61,10.83 [6.50-18.04],5.740964012406064e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASE10,Inactive ribonuclease-like protein 10,2059,54,2.30 [1.77-3.01],7.969204711154682e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASE4,Ribonuclease 4,2055,58,6.49 [4.14-10.18],3.8704440069493284e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASE6,Ribonuclease K6,2113,60,2.64 [2.06-3.37],1.1689393869274668e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASET2,Ribonuclease T2,2482,84,21.04 [12.70-34.85],2.7260970396720634e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNF149,E3 ubiquitin-protein ligase RNF149,2059,54,16.87 [9.62-29.58],5.952725153344583e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ROBO4,Roundabout homolog 4,2059,54,7.12 [1.75-28.93],0.0061117733787128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,2457,82,9.80 [6.38-15.05],1.883363732440716e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RSPO1,R-spondin-1,2437,83,5.08 [2.96-8.72],3.579599630503868e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RSPO3,R-spondin-3,2475,84,8.77 [6.02-12.77],9.958077136004537e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RTBDN,Retbindin,2439,83,9.31 [5.43-15.97],5.107305751531247e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RTN4R,Reticulon-4 receptor,2475,84,6.17 [4.26-8.94],6.05409610350124e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100A4,Protein S100-A4,2456,83,0.55 [0.40-0.74],0.0001098718284718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100G,Protein S100-G,2118,60,1.88 [1.28-2.76],0.0013403503558209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100P,Protein S100-P,2415,83,1.56 [1.27-1.93],2.691508758794912e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SART1,U4/U6.U5 tri-snRNP-associated protein 1,2060,56,1.87 [1.29-2.70],0.0008523202246881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SBSN,Suprabasin,2127,58,5.08 [2.92-8.83],8.433368577106898e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCARA5,Scavenger receptor class A member 5,2476,84,13.44 [8.92-20.24],1.7010178206348387e-35
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCARB2,Lysosome membrane protein 2,2389,83,8.39 [6.35-11.08],1.128822391436371e-50
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCARF1,Scavenger receptor class F member 1,2490,84,2.56 [1.70-3.85],6.358670778663078e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCARF2,Scavenger receptor class F member 2,2476,84,7.74 [5.54-10.82],3.2605429376762024e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCG2,Secretogranin-2,2466,84,15.88 [10.24-24.62],4.4733653708957855e-35
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCG3,Secretogranin-3,2467,83,4.76 [2.76-8.19],1.8203931793664568e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCGB1A1,Uteroglobin,2462,83,4.69 [3.25-6.76],1.183286544628607e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCGB3A2,Secretoglobin family 3A member 2,2471,83,1.35 [1.15-1.58],0.0001776248038194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCGN,Secretagogin,2404,82,2.97 [2.16-4.08],1.852644096200396e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCN4B,Sodium channel subunit beta-4,2059,54,3.98 [2.76-5.73],1.4097533278912377e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCRG1,Scrapie-responsive protein 1,2122,60,7.82 [4.32-14.16],1.0943901450135514e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SDC1,Syndecan-1,2457,82,3.54 [2.57-4.87],7.451335565935517e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SDC4,Syndecan-4,2457,82,0.48 [0.33-0.69],8.42211922273207e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SDK2,Protein sidekick-2,2085,56,1.85 [1.21-2.85],0.0049241548351112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SELE,E-selectin,2490,84,1.59 [1.13-2.24],0.0075082515208971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEMA3F,Semaphorin-3F,2457,82,11.29 [6.19-20.60],2.7669661907062884e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEMA4C,Semaphorin-4C,2439,83,1.67 [1.25-2.22],0.0004308263675668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEMA6C,Semaphorin-6C,2062,59,2.27 [1.31-3.94],0.0035369005150683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEMA7A,Semaphorin-7A,2485,84,3.10 [1.89-5.10],8.367336125234921e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEPTIN8,Septin-8,2109,60,5.65 [3.63-8.79],1.5949597154346418e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINB8,Serpin B8,2490,84,1.58 [1.31-1.90],1.412066108032321e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINF1,Pigment epithelium-derived factor,2095,59,17.00 [7.22-39.98],8.535542403380438e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEZ6,Seizure protein 6 homolog,2076,58,2.47 [1.40-4.37],0.0018921159401437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEZ6L,Seizure 6-like protein,2456,83,7.90 [4.95-12.61],4.4764307243355016e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEZ6L2,Seizure 6-like protein 2,2439,83,2.98 [1.78-4.98],3.339120147674432e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SFRP1,Secreted frizzled-related protein 1,2429,83,2.55 [1.99-3.25],6.143036438363426e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SFRP4,Secreted frizzled-related protein 4,2085,56,3.47 [1.89-6.38],6.377160647369788e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SFTPA1,Pulmonary surfactant-associated protein A1,2383,81,1.47 [1.12-1.93],0.0051144054679148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC1,Sialoadhesin,2472,83,5.19 [3.58-7.51],3.009357411963925e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC10,Sialic acid-binding Ig-like lectin 10,2461,84,4.23 [3.14-5.69],1.7447784172408855e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC5,Sialic acid-binding Ig-like lectin 5,2467,84,1.75 [1.39-2.21],2.0207319541201093e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC6,Sialic acid-binding Ig-like lectin 6,2475,84,7.93 [5.00-12.55],1.083131337363086e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC7,Sialic acid-binding Ig-like lectin 7,2457,82,3.90 [2.12-7.17],1.2471801454690131e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC8,Sialic acid-binding Ig-like lectin 8,2059,54,1.98 [1.22-3.21],0.0058484327112389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,2466,83,2.87 [1.85-4.47],2.864374206027347e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIRPB1,Signal-regulatory protein beta-1,2455,83,6.20 [4.47-8.59],6.2786286722399e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLAMF1,Signaling lymphocytic activation molecule,2404,82,2.63 [1.94-3.57],4.820902963950126e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLAMF6,SLAM family member 6,2383,81,2.06 [1.38-3.05],0.0003646851175418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLAMF7,SLAM family member 7,2461,84,1.99 [1.48-2.69],6.696433240808402e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLAMF8,SLAM family member 8,2383,81,2.19 [1.56-3.07],5.654554040660229e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC39A14,Zinc transporter ZIP14,2393,81,2.37 [1.81-3.12],5.110908839889522e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC39A5,Zinc transporter ZIP5,2461,84,1.81 [1.52-2.15],1.6446836212416228e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC4A1,Band 3 anion transport protein,2130,58,0.44 [0.24-0.80],0.0069460509729981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLITRK1,SLIT and NTRK-like protein 1,2062,59,3.17 [1.69-5.95],0.0003324213284888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLITRK2,SLIT and NTRK-like protein 2,2475,84,3.55 [2.27-5.55],2.8560621840441253e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLITRK6,SLIT and NTRK-like protein 6,2415,83,4.76 [3.26-6.95],6.152056455032622e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLMAP,Sarcolemmal membrane-associated protein,2124,60,1.44 [1.09-1.90],0.0098829530266539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLURP1,Secreted Ly-6/uPAR-related protein 1,2116,58,6.75 [4.27-10.69],3.4987008932297313e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMOC1,SPARC-related modular calcium-binding protein 1,2475,84,4.65 [3.11-6.97],8.588768729070397e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMOC2,SPARC-related modular calcium-binding protein 2,2472,83,7.15 [5.14-9.94],1.4919855118812716e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMTN,Smoothelin,2112,60,1.44 [1.14-1.81],0.0024986179178935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNCG,Gamma-synuclein,2437,83,4.02 [3.07-5.26],3.4907043252556514e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNRPB2,U2 small nuclear ribonucleoprotein B'',2116,60,1.56 [1.20-2.03],0.0008058960735386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SORBS1,Sorbin and SH3 domain-containing protein 1,2118,60,1.84 [1.37-2.46],4.238834304619728e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SORCS2,VPS10 domain-containing receptor SorCS2,2383,81,6.88 [4.85-9.75],2.7299706132979407e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SORD,Sorbitol dehydrogenase,2464,83,0.65 [0.51-0.82],0.0003536844411372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SOST,Sclerostin,2457,82,2.49 [1.56-3.95],0.0001144915479948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SOX9,Transcription factor SOX-9,2076,58,6.27 [2.46-16.02],0.0001235604984959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,2118,60,2.81 [1.79-4.40],6.625977880321806e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPARCL1,SPARC-like protein 1,2451,82,5.41 [3.01-9.73],1.7327954988591522e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPESP1,Sperm equatorial segment protein 1,2122,60,2.42 [1.32-4.43],0.0042604149462855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK1,Serine protease inhibitor Kazal-type 1,2467,84,5.77 [4.37-7.60],1.9159870558030149e-35
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK2,Serine protease inhibitor Kazal-type 2,2085,56,5.04 [3.04-8.36],3.58413127423365e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK4,Serine protease inhibitor Kazal-type 4,2461,84,2.98 [2.42-3.66],4.769541232817102e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK5,Serine protease inhibitor Kazal-type 5,2467,84,6.89 [4.39-10.83],5.524896485527616e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK6,Serine protease inhibitor Kazal-type 6,2475,84,3.08 [2.12-4.48],4.085832800766963e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINT1,Kunitz-type protease inhibitor 1,2460,84,3.98 [2.38-6.65],1.449167203291319e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINT2,Kunitz-type protease inhibitor 2,2472,83,4.11 [2.87-5.89],1.2365968604385691e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPOCK1,Testican-1,2437,83,0.32 [0.18-0.58],0.0002018965132544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPON1,Spondin-1,2467,83,5.90 [4.14-8.41],9.250129958064252e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPON2,Spondin-2,2448,82,16.24 [10.41-25.35],1.2803213195630767e-34
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPP1,Osteopontin,2485,84,4.14 [3.06-5.61],5.2299178050638605e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPRING1,SREBP regulating gene protein,2044,59,1.49 [1.12-1.98],0.0057198158130007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPRR3,Small proline-rich protein 3,2116,60,2.05 [1.60-2.64],1.9150316120698444e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,2457,82,0.81 [0.70-0.93],0.0037513041412863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",2439,83,1.88 [1.44-2.45],3.5254876093887168e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",2490,84,4.11 [2.32-7.26],1.2006457592043597e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STC1,Stanniocalcin-1,2476,84,2.57 [1.85-3.57],1.8341044433359562e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STC2,Stanniocalcin-2,2462,83,9.39 [4.31-20.44],1.6677086619844125e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STX4,Syntaxin-4,2439,83,1.44 [1.13-1.85],0.0036780087058702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUSD4,Sushi domain-containing protein 4,2117,60,1.90 [1.46-2.47],1.904209260329075e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUSD5,Sushi domain-containing protein 5,2077,55,10.93 [5.76-20.76],2.7197517696526977e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SWAP70,Switch-associated protein 70,2124,60,1.96 [1.21-3.17],0.0061751203468618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SYT1,Synaptotagmin-1,2116,60,2.42 [1.78-3.29],1.796729005701614e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TACSTD2,Tumor-associated calcium signal transducer 2,2165,77,5.79 [3.37-9.92],1.7421501295527404e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TAFA5,Chemokine-like protein TAFA-5,2439,83,6.86 [5.04-9.34],1.5839501287314535e-34
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TCL1A,T-cell leukemia/lymphoma protein 1A,2437,83,0.73 [0.61-0.88],0.0007924471366436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TCN2,Transcobalamin-2,2485,84,5.95 [4.10-8.64],6.613634010556575e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TCOF1,Treacle protein,2122,60,2.20 [1.32-3.69],0.0026902584230383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TEX101,Testis-expressed protein 101,2076,58,1.93 [1.33-2.79],0.0004870914358993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFF1,Trefoil factor 1,2455,84,2.27 [1.96-2.62],1.5498030127922452e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFF2,Trefoil factor 2,2471,83,2.96 [2.43-3.61],1.0998399213562195e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFF3,Trefoil factor 3,2444,82,2.83 [2.36-3.39],2.623616761256594e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFPI2,Tissue factor pathway inhibitor 2,2453,83,1.89 [1.47-2.42],5.516685811590333e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFRC,Transferrin receptor protein 1,2463,83,1.86 [1.19-2.92],0.0065553803042119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TG,Thyroglobulin,2117,60,1.38 [1.14-1.68],0.0009651058154114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFA,Protransforming growth factor alpha,2461,84,2.68 [1.97-3.64],2.935145179129651e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFB1,Transforming growth factor beta-1 proprotein,2484,84,2.14 [1.49-3.07],4.206274400160279e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFBR1,TGF-beta receptor type-1,2062,59,4.86 [2.48-9.52],4.191330745911187e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFBR2,TGF-beta receptor type-2,2456,83,6.34 [4.93-8.16],6.843493852897152e-47
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFBR3,Transforming growth factor beta receptor type 3,2490,84,7.86 [5.28-11.68],2.2938149006571112e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGOLN2,Trans-Golgi network integral membrane protein 2,2130,61,20.35 [11.34-36.50],5.2645920549028984e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THBD,Thrombomodulin,2457,82,7.39 [5.23-10.46],1.263761714022112e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THBS2,Thrombospondin-2,2467,84,1.95 [1.39-2.74],0.0001021769360811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THBS4,Thrombospondin-4,2460,83,1.68 [1.14-2.48],0.0082885488468706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THOP1,Thimet oligopeptidase,2449,81,0.42 [0.25-0.70],0.0008210025690603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THY1,Thy-1 membrane glycoprotein,2476,84,11.25 [7.40-17.10],9.299639203353069e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,2091,58,1.53 [1.22-1.91],0.0001911475204738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIMP1,Metalloproteinase inhibitor 1,2425,82,6.88 [4.87-9.73],7.522644091638608e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIMP2,Metalloproteinase inhibitor 2,2122,60,2.19 [1.57-3.06],4.1941310399491214e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIMP4,Metalloproteinase inhibitor 4,2467,84,2.80 [1.85-4.24],1.241943957723283e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TINAGL1,Tubulointerstitial nephritis antigen-like,2453,82,18.27 [8.69-38.43],1.853827288516108e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMOD4,Tropomodulin-4,2044,59,2.57 [1.47-4.47],0.0008754048689913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMPRSS11D,Transmembrane protease serine 11D,2109,60,3.53 [2.51-4.97],3.6803902417119073e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMPRSS15,Enteropeptidase,2439,83,1.38 [1.12-1.71],0.0030217011114796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMSB10,Thymosin beta-10,2467,84,1.57 [1.22-2.02],0.0004785349206506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNC,Tenascin,2464,83,1.83 [1.26-2.66],0.0014584064972642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,2437,83,3.68 [2.93-4.61],1.3904470087163924e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,2437,83,1.79 [1.58-2.02],2.5395971824173783e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,2470,84,1.92 [1.28-2.89],0.0016787719516727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,2490,84,6.63 [5.06-8.68],9.632248761550733e-43
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,2462,83,5.58 [3.27-9.51],2.5971745570839985e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,2456,83,8.96 [6.28-12.80],1.56417948332819e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,2467,83,3.67 [2.89-4.66],1.8157537295417478e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,2404,82,2.68 [1.94-3.70],1.9850949980623064e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,2467,83,8.53 [6.16-11.81],3.433170722727125e-38
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,2085,56,5.34 [3.05-9.36],4.8731730335230765e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,2475,84,5.73 [4.40-7.46],1.8647368952131154e-38
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,2467,84,16.10 [11.30-22.93],2.2579525804134916e-53
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,2467,84,2.21 [1.91-2.56],4.079866338504097e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,2476,84,16.43 [10.49-25.74],2.5317637591141607e-34
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,2484,84,7.13 [5.24-9.71],7.972267872555446e-36
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,2437,83,2.35 [1.89-2.92],1.6091542247359663e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,2476,84,3.07 [2.28-4.14],1.452637553382957e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,2437,83,3.37 [2.77-4.10],8.69965477380266e-34
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFSF13,Tumor necrosis factor ligand superfamily member 13,2472,83,10.39 [5.99-18.03],8.853481303286954e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,2489,84,2.78 [1.64-4.73],0.0001516421082672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNR,Tenascin-R,2437,83,2.07 [1.33-3.21],0.0012257547333149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPMT,Thiopurine S-methyltransferase,2383,81,0.53 [0.40-0.70],1.1223540766445565e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPP1,Tripeptidyl-peptidase 1,2444,83,1.76 [1.26-2.47],0.0009290300629392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPSAB1,Tryptase alpha/beta-1,2486,84,2.06 [1.38-3.07],0.0003858432514455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPSD1,Tryptase delta,2118,60,2.84 [1.90-4.25],3.300491576748921e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TREM2,Triggering receptor expressed on myeloid cells 2,2462,83,1.97 [1.45-2.67],1.4178833147995317e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TREML2,Trem-like transcript 2 protein,2467,84,4.06 [2.67-6.16],4.5761008234499615e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRIAP1,TP53-regulated inhibitor of apoptosis 1,2475,84,1.66 [1.22-2.26],0.0011699759200103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TXNDC5,Thioredoxin domain-containing protein 5,2476,84,1.73 [1.32-2.28],7.79834240964172e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",2062,59,2.22 [1.47-3.36],0.0001591262161905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UBQLN3,Ubiquilin-3,2060,56,1.53 [1.21-1.93],0.0003017450169985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ULBP2,UL16-binding protein 2,2437,83,9.91 [6.85-14.35],5.225770370891139e-34
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UMOD,Uromodulin,2484,84,0.32 [0.25-0.42],3.3470793994893373e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UNC5D,Netrin receptor UNC5D,2062,59,3.10 [1.81-5.29],3.59759970487283e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UROD,Uroporphyrinogen decarboxylase,2085,56,0.53 [0.35-0.79],0.0019946306574795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",USP28,Ubiquitin carboxyl-terminal hydrolase 28,2116,60,2.80 [1.99-3.93],3.156496337380921e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VASN,Vasorin,2420,81,7.84 [4.61-13.32],2.7825029144465958e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VCAM1,Vascular cell adhesion protein 1,2464,83,6.50 [3.86-10.94],1.928893290351568e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VCAN,Versican core protein,2476,84,3.35 [1.80-6.24],0.0001413085601804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VEGFA,Vascular endothelial growth factor A,2481,84,2.23 [1.66-2.99],1.174996950553538e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VEGFB,Vascular endothelial growth factor B,2062,59,4.93 [2.34-10.39],2.6390367956629555e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VEGFD,Vascular endothelial growth factor D,2485,84,4.51 [3.05-6.66],4.33485661719928e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VGF,Neurosecretory protein VGF,2118,60,6.54 [3.61-11.86],5.856891411626383e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VIT,Vitrin,2122,60,3.87 [2.10-7.13],1.3926648320482925e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VMO1,Vitelline membrane outer layer protein 1 homolog,2439,83,3.54 [2.60-4.81],7.300075564069277e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,2060,56,2.20 [1.22-3.98],0.008609655373015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSIG2,V-set and immunoglobulin domain-containing protein 2,2117,60,2.72 [2.12-3.47],1.5871472173530873e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSIG4,V-set and immunoglobulin domain-containing protein 4,2462,83,9.25 [6.79-12.62],5.64712142661946e-45
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSTM1,V-set and transmembrane domain-containing protein 1,2393,81,1.91 [1.34-2.72],0.0003371684045045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VWC2,Brorin,2429,83,8.43 [5.91-12.02],4.716864720479245e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VWC2L,von Willebrand factor C domain-containing protein 2-like,2118,60,1.79 [1.27-2.54],0.0009158181457589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WFDC1,WAP four-disulfide core domain protein 1,2080,59,1.57 [1.19-2.09],0.0016621875203357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WFDC12,WAP four-disulfide core domain protein 12,2471,84,2.02 [1.56-2.63],1.08878174756508e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,2335,77,6.19 [4.83-7.93],2.740263447515464e-47
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",2467,83,5.00 [2.89-8.63],7.827940015704321e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WNT9A,Protein Wnt-9a,2404,82,5.08 [3.61-7.16],1.406195498872774e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",XCL1,Lymphotactin,2475,84,1.63 [1.27-2.08],9.227806680391814e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",XG,Glycoprotein Xg,2476,84,6.80 [4.87-9.51],3.010972819596839e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",XPNPEP2,Xaa-Pro aminopeptidase 2,2456,83,0.78 [0.66-0.91],0.0021849490312311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",YAP1,Transcriptional coactivator YAP1,2116,60,18.00 [10.92-29.65],7.814726830417563e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZBTB17,Zinc finger and BTB domain-containing protein 17,2415,83,1.88 [1.42-2.49],1.0416125030924008e-05
